British Biotech Pockets Massive Series C for its CAR-T Cancer Therapies – Labiotech.eu (blog)
|
British Biotech Pockets Massive Series C for its CAR–T Cancer Therapies
Labiotech.eu (blog) Autolus, based in London, has raised €68M in Series C to continue developing its T cell immunotherapies for cancer treatment. Autolus focuses on developing engineered T cell immunotherapies to beat cancer. Its pipeline includes therapies targeted at … |
